Nanog - Nanog homeobox Gene

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 414065

Summary

Predicted to enable several functions, including DNA-binding transcription factor activity, RNA polymerase II-specific; RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity; and identical protein binding activity. Involved in several processes, including cellular response to erythropoietin; cellular response to rapamycin; and multidimensional cell growth. Located in nucleus. Used to study colon Cancer. Orthologous to several human genes including NANOG (Nanog homeobox). [provided by Alliance of Genome Resources, Apr 2022]

Nanog Products (1)

mRNA Protein Name
NM_001100781.1 NP_001094251.1 homeobox protein NANOG

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
involved in cellular response to erythropoietin IEP
IEP: Inferred from expression pattern
24855555 RGD
involved in cellular response to rapamycin IEP
IEP: Inferred from expression pattern
24296616 RGD
involved in multidimensional cell growth IEP
IEP: Inferred from expression pattern
23273767 RGD
involved in negative regulation of transcription by RNA polymerase II IDA
IDA: Inferred from direct assay
23924954 RGD
involved in response to organic cyclic compound IEP
IEP: Inferred from expression pattern
24134786 RGD
involved in stem cell differentiation IEP
IEP: Inferred from expression pattern
22211239 RGD
involved in stem cell population maintenance IEP
IEP: Inferred from expression pattern
20352099 RGD
involved in tissue regeneration IEP
IEP: Inferred from expression pattern
19845688 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

homeobox protein NANOG

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (2)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0356A Ciprofloxacin monohydrochloride 99.86% Unkown
HY-B0356B Ciprofloxacin hydrochloride monohydrate 99.88% Yes

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-17602 Amcasertib Inducer 98.03% Phase 2

Pre-clinical Phase

Bioactive Molecules (16)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-12303 OAC1 Activator 99.85% Unkown
HY-18772 O4I2 99.18% Unkown
HY-18771 O4I1 Activator 98.05% Unkown
HY-119672 Oct4 inducer-1 Activator 99.92% Unkown
HY-10321G PD173074 (GMP) Inhibitor / Unkown
HY-129108 9-cis-UAB30 / Unkown
HY-168566 EV206 Inhibitor 99.62% Unkown
HY-168885 ZSH-512 98.37% Unkown
HY-179339 LSD1-IN-46 Inhibitor / Unkown
HY-B0356G Ciprofloxacin (GMP) / Unkown
HY-RS09019 NANOG Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-119666 Rooperol Activator / Unkown
HY-174574 Human NANOG mRNA / Unkown
HY-N15201 Betavulgarin Inhibitor / Unkown
HY-RS19720 Nanog Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS26216 Nanog Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Nanog NCBI NCBI:79923